Dabrafenib vs Dabrafenib + Trametinib in <i>BRAF</i>-Mutated Radioactive Iodine Refractory Differentiated Thyroid Cancer- Results of a Randomized, Phase 2, Open-Label, Multicenter Trial
SSRN Electronic Journal（2022）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要